Navigation Links
Lifesciences IT Spending to Experience Mature Growth Rates Despite Economic Slowdown, Declares Frost & Sullivan
Date:10/20/2009

LONDON, Oct. 20 /PRNewswire/ -- The global recession will have limited effect on the lifesciences industry. However, internal factors and external issues such as weak product pipelines, generic competition and declining market shares are pressurising lifesciences companies to cut down their IT budgets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.healthcareIT.frost.com), Competitive Profiling of Market Participants in Lifesciences-IT, finds that the market was worth $26.5 billion in 2008 and is estimated to reach $41.6 billion in 2015.

"SaaS technology will be adopted by pharmaceutical companies as it is cost effective and offers enhanced flexibility options," notes Frost & Sullivan Industry Analyst E. Sujith. "The lifesciences industry is focusing on outsourcing its operations to reduce costs, creating a new market for vendors of IT solutions."

Pharmaceutical companies are moving to outsource operations to countries including India, China and Singapore as a cost-cutting measure. Despite the pharmaceutical industry increasingly rationalising and rightsizing its outsourcing, this still presents a substantial market.

Pharmaceutical companies are reducing their IT budgets. They are also rationalising new purchases due to uncertainties in the industry.

"Pharmaceutical and biotechnology companies are confronting issues such as a flood of generics, intensified competition, shrinking drug pipelines and lowered cash flows," cautions Sujith. "This is discouraging them from investing in IT-related expenses."

Accordingly, service providers should revise their pricing models. These could shift from effort-based pricing methods to potentially more successful outcome-based partnership contracts.

"The performance-based pricing model has been widely accepted in the marketplace during the recession and vendors would benefit by following this model," advises Sujith. "The IT cost efficiency compared to productivity of the business in exploring the cost is now a corporate wide strategy for maximising business productivity from the costs."

Competitive Profiling of Market Participants in Lifesciences-IT is part of the Healthcare & Life Sciences IT Growth Partnership Services programme, which also includes research in the following markets: European Medical Equipment Services Market, European market for Medical Display Monitors, Archiving Requirements for Image Management and European PACS Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brochure will be sent to you by e-mail.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Competitive Profiling of Market Participants in Lifesciences-IT

M3E1

    Contact:
    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 7703343
    E: katja.feick@frost.com

http://www.frost.com

SOURCE Frost & Sullivan


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
2. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
3. Unemployment, Health Care Spending Affect Mortality
4. Cancer Drugs Emerging as Top Driver of Specialty Drug Spending
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
7. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
8. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
11. REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... VMS BioMarketing as senior vice president of sales, announced Andrea Heslin Smiley , ... the company,s business development and sales team, exploring new opportunities for VMS to empower ... ... ... ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
(Date:5/24/2016)... , May 24, 2016 ... elkaar verbindt, zodat zij collectief patiënten kunnen behandelen, hun ... is het idee achter de nieuwe en revolutionaire MDLinking ... van de Nederlandse vaatchirurg dr. Hans Flu en oncologisch ... app, die inmiddels beschikbaar is, wordt op dinsdag 24 ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... ... To better understand the impact of lung cancer in women, the American Lung ... Today, the Lung Association announced Sharad Goyal, MD , as the recipient of The ... Lung Association’s LUNG FORCE initiative, which raises awareness of the impact of lung cancer ...
(Date:5/24/2016)... IN (PRWEB) , ... May 24, 2016 , ... ... benefits advisory organization, is pleased to welcome new Partner Firm Austin & Co., ... personalized, consultative approach to insurance, employee benefits, HR consulting, benefits technology, and beyond. ...
(Date:5/24/2016)... ... May 24, 2016 , ... New Brunswick, New Jersey: This ... healthcare needs reach their fullest potential. To commemorate the anniversary, the hospital has themed ... Walk n’ Roll for Children’s Specialized Hospital Foundation on Saturday, May 21, at Johnson ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... for physical disease or injury that focuses on repairing the musculoskeletal and neuromuscular ... With an emphasis on functional restoration, NYDNRehab began providing treatments for physical therapy ...
(Date:5/24/2016)... ... May 24, 2016 , ... Growing in popularity, more and more ... products are available and easily accessible. Whether someone chooses to cut gluten out of ... certain diet, King Kullen Grocery stocks their shelves with many different gluten-free products all ...
Breaking Medicine News(10 mins):